Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by

Glenn Fitzpatrick1,2, Danielle Nader1,2, Rebecca Watkin1,2

  • 1Cardiovascular Infection Research Group, Dublin, Ireland.

Insights

Endothelial exosomes from Staphylococcus aureus infections promote a pro-inflammatory monocyte response. These exosomes, containing miR-99, dysregulate cytokine production via mechanistic target of rapamycin (mTOR) signaling.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Sepsis pathophysiology involves hyper-inflammation and multi-organ failure.
  • The vascular endothelium is increasingly recognized for its role in early sepsis progression.
  • Endothelial-derived exosomes are implicated in intercellular communication during infection.

Purpose of the Study:

  • To investigate the role of endothelial-derived exosomes in sepsis-induced monocyte activation.
  • To identify specific molecular mechanisms by which exosomes modulate monocyte inflammatory responses.
  • To explore the involvement of microRNAs (miRNAs) and mechanistic target of rapamycin (mTOR) signaling.

Main Methods:

  • Isolation and characterization of exosomes from Staphylococcus aureus-infected and healthy endothelial cells.
  • Treatment of monocytes with isolated exosomes to assess phenotypic and cytokine production changes.
  • miRNA profiling of exosomes and manipulation of miR-99 and mTOR pathways in monocytes.

Main Results:

  • Exosomes from S. aureus-infected endothelial cells induced CD11b and MHCII expression and dysregulated cytokine production in monocytes.
  • miR-99 upregulation was identified in exosomes from infected endothelial cells.
  • Modulation of miR-99 and mTOR pathways significantly altered IL-6 and IL-10 production in monocytes.

Conclusions:

  • Endothelial-derived exosomes contribute to a pro-inflammatory monocyte phenotype during sepsis.
  • Dysregulated expression of miR-99a and miR-99b within exosomes drives these changes via mTOR.
  • Targeting exosomal miRNAs presents a potential therapeutic strategy for sepsis-induced inflammation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K